Jalca Combination Tablets, containing Dolutegravir Sodium and Rilpivirine Hydrochloride, are used to treat human immunodeficiency virus (HIV-1) infection in adults who are virologically suppressed. This medication, sometimes known by the brand name Juluca, is manufactured by ViiV Healthcare. The YJ code for this internal medicine is 6250115F1020, and the standard dosage is one tablet.
Jalca Combination Tablets
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
